Conquering Diseases

A Study Of An Investigational Drug In Subjects With Moderately To Severely Active Ulcerative Colitis.

Description

Seeking Men and Women over 18 years of age with moderately to severely active ulcerative colitis for participation in a study of an investigational product called Efavaleukin Alfa

Overview

We are studying the effect and safety of an investigational product called Efavaleukin Alfa for individuals with moderately to severely active ulcerative colitis.

What we're hoping for

Efavaleukin Alfa for individuals with moderately to severely active ulcerative colitis.

Additional Information

ClinicalTrials.gov Identifier: NCT04987307

 Principal Investigator

JeanMarie  Houghton, MD, PhD

University of Massachusetts Medical School

 Study Contact

Anne  Foley

Anne.foley@umassmemorial.org

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989